In line with this, the area of visceral AT, deep and superficial subcutaneous AT depots decreased significantly (all P < 1 × 10−20, Table 1), and obesity-associated metabolic features such as HbA1c and insulin levels clearly improved (all P < 0.01, Table 1). Here, INS is linked to obesity disorder.